Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,171 total articles
Lyft Inc. (NASDAQ: LYFT) Chief Financial Officer Erin Brewer sold 15,000 Class A Common Stock shares on June 12, 2026, realizing approximately $203,887 through a Rule 10b5-1 trading plan. The transaction reduces her indirect holdings via the Erin M. Brewer 2022 Trust while she retains direct ownership of 1,205,200 shares, including restricted stock…
CuriosityStream Inc. (NASDAQ: CURI) director Patrick J. Keeley sold 31,559 shares of common stock on June 12, 2026, with a total transaction value of $85,155. The shares were purchased directly by the company under its share repurchase program at a price of $2.6983 per share, determined by a five-day volume-weighted average price approved by the Au…
On June 12, 2026, multiple reporting persons, including the investment fund Silver Lake Partners IV, L.P. and Dell Technologies Inc. (NYSE:DELL) director Egon Durban, reported the sale of Dell Class C Common Stock valued at $15,938,112. The sales, largely attributed to Silver Lake Partners IV, L.P., consisted of 39,537 shares traded at prices betwe…
Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), executed a sale of 6,800 shares of the company’s common stock on June 15, 2026. The transaction, valued at $117,183, was conducted under a pre-arranged 10b5-1 trading plan adopted on March 14, 2026. The shares were sold at prices ranging from $17.00 to $17.47 per share, resulting…
Huntington Bancshares Inc. (NASDAQ: HBAN) reported a significant insider transaction as director James D. Rollins III sold 223,522 shares on June 12, 2026. The sale, valued at approximately $3.88 million, occurs against a backdrop of strong first-quarter financial performance and renewed shareholder confidence demonstrated at the recent annual meet…
Applied Optoelectronics (NASDAQ: AAOI) Senior Vice President and Asia General Manager Yeh Shu-Hua executed significant share disposals on June 12, 2026, totaling approximately $8.8 million. The transactions include a direct sale of 28,826 shares and the surrender of 23,397 shares to meet tax obligations. This activity occurs against a backdrop of a…
Stefan J. Murry, Chief Financial Officer of Applied Optoelectronics, Inc. (NASDAQ:AAOI), executed a significant divestment of company stock on June 12, 2026. The transactions involved the sale of 33,000 shares for $5,495,490 and the disposal of 30,330 shares valued at $5,240,417 to cover tax withholding obligations. This activity occurs against a b…
Bruce R. Berkowitz, a significant shareholder in ST JOE Co (NASDAQ:JOE), and Fairholme Funds Inc. have executed a series of share sales totaling approximately $12.08 million. The transactions, documented in a recent Securities and Exchange Commission filing, occurred over three consecutive trading days in mid-June. This divestment comes as the real…
Vulcan Materials Co. (VMC) Senior Vice President David P. Clement executed a sale of 2,212 shares on June 15, 2026, totaling $646,545 at a price of $292.29 per share. This transaction leaves Mr. Clement with 8,716 directly held shares and 1,254.60 shares within a 401(k) plan. The sale occurs as Vulcan Materials reports significant Q1 2026 financial…
Christopher D. Krusmark, Executive Vice President and Retail & People Officer at Sleep Number Corp (NASDAQ:SNBR), executed a transaction involving the sale of common stock on June 12, 2026. The sale, totaling $2,065, occurred as the company faces substantial financial headwinds, including a recent plunge in share price and ongoing Chapter 11 bankru…
Omada Health President Shao Wei-Li sold 4,589 shares of the company's common stock on June 12, 2026, realizing proceeds of $79,117. The transaction was executed at a weighted average price of $17.2407 per share, with prices ranging from $17.10 to $17.54. This sale was conducted under a pre-arranged 10b5-1 trading plan established on March 13, 2026.…
Timothy Coughlin, a director at Travere Therapeutics, Inc. (NASDAQ:TVTX), executed a sale of 10,000 shares on June 12, 2026, totaling $500,747. The transaction, conducted under a Rule 10b5-1(c) trading plan established in November 2025, follows the exercise of stock options on the same day. This insider activity occurs amidst significant corporate …
Jeremy Prahm, Chief Investment Officer at Finance of America Companies Inc. (NASDAQ: FOA), completed a stock transaction on June 15, 2026, selling 8,860 shares of Class A Common Stock. The sale, executed under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025, totaled approximately $181,499. This transaction occurs as the company nav…
James J. Goetz, a director at Palo Alto Networks Inc. (NASDAQ:PANW), executed the sale of 20,000 shares of common stock through a family trust on June 12, 2026. The transaction, valued at approximately $5.6 million, occurred at prices ranging from $277.8856 to $281.6429 per share. Following the sale, the family trust retains an indirect holding of …
Datadog director Amit Agarwal sold approximately $4.63 million worth of Class A common stock on June 12, 2026, executing the sale through a pre-arranged 10b5-1 plan. The transaction occurred as the company's stock has surged 66% over the last six months, reaching a market capitalization of $82.7 billion. Alongside the sale, Agarwal converted Class …
Datadog, Inc. (NASDAQ: DDOG) Director Michael James Callahan executed a significant stock sale on June 12, 2026, divesting approximately $26.1 million worth of Class A Common Stock. The transaction, facilitated through a pre-arranged 10b5-1 trading plan, underscores ongoing insider activity within the cloud monitoring and analytics firm. This sale …
David Young, who serves as President of Research & Development and as a director at Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), executed a direct share purchase on June 15, 2026. The transaction involved the acquisition of 2,067 shares at a price of $2.22 per share, bringing the total transaction value to $4,588. Following this acquisition, Mr. Y…
Hillary A. Hudak, Senior Vice President and Chief People Officer at Consumers Bancorp Inc. (NASDAQ: CBKM), has increased her direct ownership in the company through recent common stock acquisitions. The transactions reflect continued executive participation in the firm’s equity program, coinciding with the stock trading near its 52-week high and a …
Six Flags Entertainment Corporation/NEW (NYSE:FUN) Director Rehan Jaffer has significantly increased his stake in the amusement park operator by acquiring 250,000 shares worth approximately $5.9 million. The purchases, executed on June 12 and June 15, 2026, were made through funds managed by H Partners Management, LLC. This insider buying activity …
Ouster, Inc. (NASDAQ:OUST) Chief Financial Officer Kenneth P. Gianella executed a significant divestment of company equity on June 12, 2026, selling 54,337 shares of common stock for a total value of approximately $2,109,525. The transaction was facilitated through a Rule 10b5-1 trading plan established on August 20, 2025, and was specifically stru…
Thaddeus Weed, who serves as Vice President and Chief Financial Officer at Cogent Communications Holdings, Inc., has executed a sale of company equity. The transaction occurs against a backdrop of recent corporate restructuring, including a significant data center sale and a recent downgrade from JPMorgan. The insider activity is being monitored as…
Louisiana-Pacific Corporation (NASDAQ: LPX) director Lizanne M. Bruce executed two separate transactions on June 15, 2026, reducing her direct holdings in the building materials manufacturer. The first transaction involved a standard market sale of 1,141 shares at $78.21 each, totaling $89,237. The second transaction transferred 378 shares to her e…
Fiserv Inc. (NASDAQ:FISV) director Harry DiSimone executed a strategic equity acquisition on June 16, 2026, purchasing 2,088 shares at $48.41 each, totaling $101,080. This transaction occurs while Fiserv's stock trades near its 52-week low of $47.37, having declined approximately 71% over the past year. The timing of this insider purchase intersect…
Daniel Barber, president and chief executive officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), executed a sale of 25,000 shares on June 15, 2026, realizing $104,010 from the transaction. The divestment occurred at prices between $4.14 and $4.235 per share, with a weighted average of $4.1604. Following this activity, Barber retains direct owner…
Fiserv Inc. (NASDAQ:FISV) director Gordon M. Nixon recently executed a $371,775 purchase of company stock, acquiring 7,500 shares at $49.57 per share on June 16, 2026. This transaction brings his direct holdings to 17,656 shares. The insider buying occurs as the stock trades near its 52-week low, reflecting potential market confidence during a peri…
